£168.99

Academic Press Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside

Price data last checked 36 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£169 today · previous high £169 · all-time low £166

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 55 days · 55 data points (no recent data)

Historical
Generating forecast…
£168.99 £166.24 £166.84 £167.44 £168.04 £168.64 £169.24 26 April 2026 09 May 2026 23 May 2026 05 June 2026 19 June 2026

Price Distribution

Price distribution over 55 days • 3 price levels

Days at Price
Current Price
15 days 7 days 33 days · current 0 8 17 25 33 £166 £168 £169 Days at Price

Price Analysis

Most common price: £169 (33 days, 60.0%)

Price range: £166 - £169

Price levels: 3 different prices over 55 days

Description

Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside, Third Edition comprehensively investigates key discoveries in the field of bone biology. New aspects of bone cancer biology are treated in new chapters covering exosomes, autophagy, and metabolism. These have led to the development of entirely new areas for investigation, such as therapies which combine surgery and biological approaches. The Third Edition expands on the original overview of bone cancer development (physiology and pathophysiology), with 40% new material. Each chapter has been written by internationally recognized specialists on the bone cancer microenvironment, bone metastases, osteoclast biology in bone cancer, proteomics, bone niche, circulating tumor cells, and clinical trials. Given the global prevalence of breast and prostate cancers, knowledge of bone biology has become essential for everyone within the medical and cancer research communities. Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside continues to offer the only translational reference to cover all aspects of primary bone cancer and bone metastases. This revision opens the door to myeloma with two short chapters dedicated to this bone-associated disease. Covers the broad field of bone sarcomas and bone metastases from basic research to clinical approaches Presents comprehensive and translational overview of biological and clinical aspects of bone cancers, discussing pathophysiology from genetic and molecular levels using the most recent evidence Provides a common language for cancer researchers, bone biologists, oncologists, and radiologists to discuss bone tumors and how bone cancer metastases affects each major organ system Offers insights to research clinicians (oncologists and radiologists) into understanding the molecular basis of bone cancer, leading to more well-informed diagnoses and treatment of tumors and metastases Offers insights to bone biologists into how clinical observations and practices can feed back into the research cycle and, therefore, can contribute to the development of more targeted genomic and proteomic assays

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
26 September 2021
Listed Since
30 October 2019

Barcode

No barcode data available

Similar Products You Might Like

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
98% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£80.66 09 Jul 2026
Bone Cancer: Primary Bone Cancers and Bone Metastases
97% match

Bone Cancer: Primary Bone Cancers and Bone Metastases

Academic Press

£107.59 03 Jul 2026
Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)
97% match

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)

Humana

£79.19 06 May 2026
Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)
97% match

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)

Humana

£103.24 12 Jun 2026
Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
97% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£103.09 11 Jun 2026
Bone Cancer: Progression and Therapeutic Approaches
97% match

Bone Cancer: Progression and Therapeutic Approaches

Academic Press

£71.88 03 Jul 2026
Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)
97% match

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Springer

£100.08 03 Jul 2026
Springer - Advances in Biology and Therapy of Multiple Myeloma 2
97% match

Springer - Advances in Biology and Therapy of Multiple Myeloma 2

Springer

£107.98 05 May 2026
Treatment of Multiple Myeloma and Related Disorders
97% match

Treatment of Multiple Myeloma and Related Disorders

Cambridge University Press

£36.41 04 Jul 2026
Clinical Malignant Hematology
97% match

Clinical Malignant Hematology

McGraw-Hill Education

£201.99 17 Jun 2026
Dorfman and Czerniak's Bone Tumors
97% match

Dorfman and Czerniak's Bone Tumors

Elsevier

£224.29 07 Jul 2026
Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)
96% match

Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)

Springer

£99.39 02 Jul 2026
Horizons in Cancer Research. Volume 73: Volume 73
96% match

Horizons in Cancer Research. Volume 73: Volume 73

£113.87 13 Jun 2026
Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)
96% match

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Springer

£100.10 17 Jul 2026
Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)
96% match

Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)

Springer

£248.00 17 Jun 2026
Springer Hematologic Cancers: Molecular Pathobiology to Therapy
96% match

Springer Hematologic Cancers: Molecular Pathobiology to Therapy

Springer

£113.76 16 Jul 2026
Springer Multiple Myeloma and Plasma Cell Neoplasms Book
96% match

Springer Multiple Myeloma and Plasma Cell Neoplasms Book

Springer

£104.34 20 Jul 2026
Multiple Myeloma and Related Disorders (Hodder Arnold Publication)
96% match

Multiple Myeloma and Related Disorders (Hodder Arnold Publication)

CRC Press

£150.17 12 Jun 2026
Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)
96% match

Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)

£91.32 10 Jul 2026
Osteosarcoma in Adolescents and Young Adults: New Developments and Controversies: 62 (Cancer Treatment and Research, 62)
96% match

Osteosarcoma in Adolescents and Young Adults: New Developments and Controversies: 62 (Cancer Treatment and Research, 62)

Springer

£227.98 17 Jun 2026
Consulting Hematology and Oncology Handbook
96% match

Consulting Hematology and Oncology Handbook

Springer

£54.69 08 Jul 2026
Osteosarcoma in Adolescents and Young Adults: New Developments and Controversies: 62 (Cancer Treatment and Research, 62)
96% match

Osteosarcoma in Adolescents and Young Adults: New Developments and Controversies: 62 (Cancer Treatment and Research, 62)

Springer

£202.26 16 Jun 2026
Cancer Consult: Expertise in Clinical Practice, Volume 2: Neoplastic Hematology & Cellular Therapy
96% match

Cancer Consult: Expertise in Clinical Practice, Volume 2: Neoplastic Hematology & Cellular Therapy

Wiley

£96.38 02 Jul 2026
Biology and Management of Multiple Myeloma (Current Clinical Oncology)
96% match

Biology and Management of Multiple Myeloma (Current Clinical Oncology)

Humana

£68.37 09 Jul 2026